Business
Beyond Cancer™ to Present Two Posters for Ultra-High Concentration Nitric Oxide (UNO) Therapy at the 2023 AACR Annual Meeting
Proffered abstracts accepted for presentation at the American Association for Cancer Research (AACR) Annual Meeting were released publicly today at 4:30 PM

About this update from Beyond Air, Inc.
[{"type":"text","content":"Proffered abstracts accepted for presentation at the American Association for Cancer Research (AACR) Annual Meeting were released publicly today at 4:30 PM EDT\nGARDEN CITY, N.Y. and HAMILTON, Bermuda, March 14, 2023 (GLOBE NEWSWIRE) -- Beyond Cancer, Ltd., an affiliate of Beyond Air, Inc. (NASDAQ: XAIR) that is developing ultra-high concentration nitric oxide (UNO) as an immunotherapeutic for solid tumors, today announced that Beyond Cancer, Ltd. will present two posters at the upcoming American Association for Cancer Research (AACR) Annual Meeting 2023, which is scheduled to be held April 14-19 in Orlando, Florida. Details of the poster presentations are as follows: Title: Intratumoral administration of ultra-high concentration nitric oxide (UNO) is more efficacious than anti-PD1 therapy in 4T1 tumor-bearing miceSession Category: ImmunologySession Title: Anticancer ImmunotherapeuticsSession Date and Time: Wednesday, Apr 19, 2023, 9:00 AM - 12:30 PM EDTLocation: Orange County Convention Center, Poster Section 22Poster Board Number: 3Abstract Number: 6327Participant: Hila Confino, PhD; Chief Scientific Officer, Beyond Cancer, Ltd. Title: Short-term exposure of cancer cells to ultra-high concentrations of nitric oxide (UNO) induces PD-L1 upregulationSession Category: ImmunologySession Title: Immune CheckpointsSession Date and Time: Wednesday, Apr 19, 2023, 9:00 AM - 12:30 PM EDTLocation: Orange County Convention Center, Poster Section 23Poster Board Number: 7Abstract Number: 6363Participant: Hila Confino, PhD; Chief Scientific Officer, Beyond Cancer, Ltd. Please note that the proffered abstracts accepted for presentation at the AACR Annual Meeting 2023 were released publicly at 4:30 PM EDT today, March 14, 2023. About Nitric Oxide Nitric Oxide (NO) is a potent molecule, naturally synthesized in the human body, proven to play a critical role in a broad array of biological functions. In the airways, NO targets the vascular smooth muscle cells that surround the small resistance arteries in the lungs. Currently, exogenous inhaled NO is used in adult respiratory distress syndrome, post certain cardiac surgeries and persistent pulmonary hypertension of the newborn to treat hypoxemia. Additionally, NO is believed to play a key role in the innate immune system and in vitro studies suggest that NO possesses anti-microbial activity not onl...